A new nanobody with unique sequence composition, expressibility and genericity for bio-diagnosis
In collaboration with the CRCT (Centre de Recherches contre le Cancer de Toulouse) with funding from INSERM Transfert, our AI technology was able to design a completely new nanobody scaffold. As targeted, the designed nanobody has high expressibility, unique fluorescence capacities for in-cell diagnosis and keeps affinity for targets with various sets of CDR loops (patent pending). A result of our hybrid AI multi-state protein design capacities.